Ankara City Hospital

Ankara, Turkey
Hospital in Ankara
Üniversiteler, 1604. Cd. No - 9 D - No - 9, 06800 Çankaya/Ankara
3,704 Beds

About Ankara City Hospital


Ankara Bilkent City Hospital is a full-service city hospital located in Ankara, Turkey. Opened in 2019, it is the biggest in the country having a total of 3,704 hospital beds.
There are 3,704 beds in Ankara City Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Ankara City Hospital Bilkent
57
Hoffmann-La Roche
17
Janssen Research & Development, LLC
11
Eli Lilly and Company
5
Turkish League Against Rheumatism
3
Ankara Yildirim Beyazıt University
2
Pfizer
2
Sinovac Research and Development Co., Ltd.
2
Akdeniz University
1
Arch Biopartners Inc.
1
Arcus Biosciences, Inc.
1
Total Rows: 28

Clinical Trials at Ankara City Hospital


During the past decade, Ankara City Hospital conducted 118 clinical trials. In the 10-year time frame, 118 clinical trials started and 4 clinical trials were completed, i.e. on average, 3.4% percent of trials that started reached the finish line to date. In the past 5 years, 99 clinical trials started and 3 clinical trials were completed. i.e. 3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years222244111134344040252500110000111100Started TrialsCompleted Trails20162017201820192020202120220204060
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
2012-02-17
2019-11-14
Completed
258
Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
2016-06-30
2023-06-30
Active, not recruiting
1,214
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
2016-11-21
2025-07-30
Recruiting
600
A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)
2017-08-25
2023-01-17
Completed
653
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis
2017-07-12
2020-11-10
Completed
741
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
2018-01-06
2023-01-04
Completed
580
A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2018-12-27
2024-12-31
Active, not recruiting
438
A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC
2019-06-10
2023-04-01
Active, not recruiting
543

Rows per page:

1–100 of 119

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Ankara City Hospital" #1 sponsor was "Ankara City Hospital Bilkent" with 57 trials, followed by "Hoffmann-La Roche" with 17 trials sponsored, "Janssen Research & Development, LLC" with 11 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored and "Turkish League Against Rheumatism" with 5 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ankara City Hospital" #1 collaborator was "Ankara City Hospital Bilkent" with 2 trials as a collaborator, "Klinar CRO" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "Düzen Laboratories Group" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAnkara City Hospital Bilkent: 57Ankara City Hospital Bilkent: 57Hoffmann-La Roche: 17Hoffmann-La Roche: 17Janssen Research &Development, LLC: 11Janssen Research &Development, LLC: 11Eli Lilly and Company: 5Eli Lilly and Company: 5Turkish League AgainstRheumatism: 3Turkish League AgainstRheumatism: 3Ankara Yildirim BeyazıtUniversity: 2Ankara Yildirim BeyazıtUniversity: 2Pfizer: 2Pfizer: 2Sinovac Research andDevelopment Co., Ltd.:2Sinovac Research andDevelopment Co., Ltd.:2Akdeniz University: 1Akdeniz University: 1Arch Biopartners Inc.: 1Arch Biopartners Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsAnkara City Hospital Bilkent: 2Ankara City Hospital Bilkent: 2Klinar CRO: 2Klinar CRO: 2Astellas Pharma Inc: 1Astellas Pharma Inc: 1Baxter HealthcareCorporation: 1Baxter HealthcareCorporation: 1Düzen Laboratories Group: 1Düzen Laboratories Group: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Gilead Sciences: 1Gilead Sciences: 1Istanbul UmraniyeTraining and ResearchHospital: 1Istanbul UmraniyeTraining and ResearchHospital: 1Jazz Pharmaceuticals: 1Jazz Pharmaceuticals: 1Koç University: 1Koç University: 1

Clinical Trials Conditions at Ankara City Hospital


According to Clinical.Site data, the most researched conditions in "Ankara City Hospital" are "Carcinoma, Non-Small-Cell Lung" (6 trials), "Covid19" (6 trials), "Postoperative Pain" (5 trials), "Cardiac Surgery" (4 trials) and "Arthritis, Psoriatic" (3 trials). Many other conditions were trialed in "Ankara City Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Ankara City Hospital


Most popular intervention types in "Ankara City Hospital" are "Drug" (46 trials), "Other" (32 trials), "Procedure" (19 trials), "Device" (10 trials) and "Diagnostic Test" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "Atezolizumab" (7 trials), "Carboplatin" (7 trials), "Paclitaxel" (5 trials) and "Pemetrexed" (5 trials). Other intervention names were less common.

Clinical Trials Genders at Ankara City Hospital


The vast majority of trials in "Ankara City Hospital" are 98 trials for "All" genders, 14 trials for "Female" genders and 7 trials for "Male" genders.

Clinical Trials Status at Ankara City Hospital


Currently, there are 59 active trials in "Ankara City Hospital". 6 are not yet recruiting, 36 are recruiting, 14 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 44 completed trials in Ankara City Hospital, 1 suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Ankara City Hospital, 4 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 29 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 37Phase 3: 37Not Applicable: 29Not Applicable: 29Phase 2: 9Phase 2: 9Phase 1: 4Phase 1: 4Phase 4: 3Phase 4: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 44Completed: 44Recruiting: 36Recruiting: 36Active, not recruiting: 14Active, not recruiting: 14Unknown status: 11Unknown status: 11Not yet recruiting: 6Not yet recruiting: 6Terminated: 4Terminated: 4Enrolling by invitation: 3Enrolling by invitation: 3Suspended: 1Suspended: 1